Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience
Luis E. Cuéllar(Instituto Nacional de Enfermedades Neoplásicas), Karen M. Winkfield(Atrium Health Wake Forest Baptist), Diana Portillo-Álvarez(Instituto Nacional de Enfermedades Neoplásicas), Alexis Holguín(Instituto Nacional de Enfermedades Neoplásicas), Joanne Jeter, Jule F Vasquez(Instituto Nacional de Enfermedades Neoplásicas), Esther Rosa Luna-Reyes(Instituto Nacional de Enfermedades Neoplásicas), Andrea Anampa‐Guzmán(Mayo Clinic in Arizona), Juan Luis de la Vallina Velarde(Instituto Nacional de Enfermedades Neoplásicas), Marco Antonio Zuñiga(National University of San Marcos)
Cited by 18
Related Papers
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement
|Journal of Clinical Oncology|2022|238
Achieving gender equity in the radiation oncology physician workforce
|Advances in Radiation Oncology|2018|72
Epidemiology, clinical aspects, outcomes and prognostic factors associated with <i>Trichosporon</i> fungaemia: results of an international multicentre study carried out at 23 medical centres
|Journal of Antimicrobial Chemotherapy|2021|46
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
|Cancer Prevention Research|2023|20
Yellow fever in South America – A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN
|Travel Medicine and Infectious Disease|2025|15